Pharma woes: Dinesh Thakur and Prashant Reddy on India’s regulatory shortcomings

<p>In their 2022 book <em>The Truth Pill</em>, lawyer Prashant Reddy T and public health activist Dinesh S Thakur explored various aspects of modern pharmacology and pharmaceutical practices in India.</p><br><p>Now, in this conversation with <em>Newslaundry</em>’s Abhinandan Sekhri on February 9, they talked about the shortcomings of pharmaceutical regulations in India. Prashant quoted a former drug controller, who said, “If I had to apply American standards of quality to the Indian industry, I’ll have to shut down more than half the plants.”</p><br><p>This lack of regulatory accountability and non-compliance with scientific methodology can have serious consequences for consumers. Dinesh and Prashant explained other pressing concerns facing healthcare in India – rising drug failures, a surge in fixed-dose combinations, and the lack of regulatory structures for ayurvedic medicines.</p><br><p>Watch.</p><br><p><strong>Venue partner: The Quorum, Gurgaon</strong></p><br><p><br></p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>